Our Long Covid Research paper is now in Preprint!
Mechanisms of Gut-Related Viral Persistence in Long Covid
The Covid research journey has been long and challenging, but incredibly rewarding thanks to the dedicated individuals and knowledge gained along the way. Our focus on Long Covid research has proven to be more complex than anticipated and is still a work in progress.
Our research team, although small, consists of 2 remarkable individuals with impressive backgrounds in academia:
- Prof Bruce Uhal, Lead International Pulmonary ACE-2 researcher from Michigan, USA.
- Prof Antony Turner, the mind behind the discovery of ACE-2 in 2000 and Serum ACE-2 in 2005 from Leeds, UK (a potential Nobel Prize winner).
We welcome your insights on our paper.
Our overarching goal is to unravel the fundamental pathophysiology that connects Long Covid, MECFS, Fibromyalgia, and other post-viral illnesses. The journey ahead is still lengthy, but our commitment to advancing medicine and research remains unwavering.
My large posting below is a write up titled Long Covid Considerations I had prepared in August 2022, on the basis of the information I had known then. Since I was not looking into any podcasts then, I sent this by mail to many individuals including well known researchers like Dr. McMillan himself. Please specifically look into points 1,2,5,12,14,15 & 17. I had clearly postulated that the LC conditions were because of viral remnants in the body, that LC must be regarded as a legacy of only 2020 and early 2021, points highlighted in this paper by Dr. McMillan. I am not a doctor, not any kind medical professional. I had also suggested that depending on where that remanats have taken residence, those organs might be affected. On treatments ( not discussed in this paper), I had said long term anti histamines must be added as part anti virals, along with condition specific medications. As I said that residual presence is a consequence of letting a full viral load build up in the infection by ignoring early treatments. One important point was considering the vaccines as a red herring in LC presentations and persistence. Writing this paper in 2024, I am not sure if this review was done on the basis of only case informations of 2020 and part 2021. The mechanistic considerations have to take into account nearly 3 years of vaccine interference with the virus and its own pathogenic behaviour in the long term illness. How would these mechanisms look like if the vaccine protein remnants were also influencing the course of this illness ? The paper should have looked into those realms.
Well done Doc. A considerable achievement! Your passion and commitment are evident in each video I watch.